Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Pharmaceutical

Irish Antibiotic Use Among EU's Highest, ECDC Data Show

Sreepriya Prasannan
Sreepriya Prasannan

NewsWritten by our team from the primary sources linked below. Reviewed, verified and approved by a human editor. How we check

Speed:
Irish Antibiotic Use Among EU's Highest, ECDC Data Show

Antibiotic use in Ireland outside hospitals was the ninth highest of 28 EU/EEA countries in 2024, at 21.1 defined daily doses per 1,000 people per day against an EU/EEA average of 18.8, figures from the European Centre for Disease Prevention and Control (ECDC) show. Ireland has ranked between 6th and 9th highest every year since 2013.

ECDC's 2024 report gives one total per country. To see which antibiotics drive Ireland's figure, Priya Life Science analysed ECDC's more detailed tables, which run to 2022, through Airmid Éireann, its open-data library. We publish this for World AMR Awareness Week, 18 to 24 November 2026.

Key Highlights:
  • Latest year, 2024: Ireland's community use was 21.1 doses per 1,000 people per day, 9th highest of 28 countries and above the EU/EEA average of 18.8 (ECDC report for 2024).
  • Detailed tables, 2022: Ireland was 8th highest of 27 countries, at 21.46 against an EU/EEA average of 16.94, just behind Malta (21.53) and Spain (21.56).
  • Trend: from 2019 to 2022, Irish community use rose 2.2% while the EU/EEA average fell 2.3%.
  • Mix: penicillins made up 48.3% of Irish community use. Ireland had the 2nd highest tetracycline use of 28 countries.
  • Hospitals: Irish hospital use, at 1.61, was close to the EU/EEA average of 1.58 and ranked 12th of 26.

Where does Ireland rank in Europe for antibiotic use?

In 2024, the latest year ECDC has reported, Irish community use was 21.1 doses per 1,000 people per day, up from 20.7 in 2023. Eight countries were higher: Greece (27.8), France (24.7), Romania (23.5), Spain (22.7), Malta (22.6), Cyprus (22.0), Bulgaria (21.4) and Poland (21.2). The Netherlands was lowest at 9.0. ECDC found no statistically significant trend for Ireland from 2020 to 2024, while 17 countries had a rising trend.

The rest of this article uses ECDC's detailed tables for 2022, which Airmid Éireann holds and which break use down by antibiotic group. ECDC revises earlier years in later reports, so the 2022 figures below differ slightly from the 2022 column in its 2024 report.

In 2022, 27 countries reported all seven main antibiotic groups for the community, which ECDC calls primary care. Ireland ranked 8th. Greece was highest at 31.11 doses per 1,000 people per day. The Netherlands was lowest at 8.31. The median country was Iceland, at 17.47.

The gap to the countries just above Ireland is small: Malta was 0.07 higher. Ireland sits in a cluster with Spain, Malta and France.

In every year from 2013 to 2022, Ireland ranked between 6th and 9th highest.

Community antibiotic use, 2022, defined daily doses per 1,000 inhabitants per day, sum of seven main groups (ECDC ESAC-Net via Airmid Éireann)
CountryDoses per 1,000 a day
Greece31.11
Romania26.09
Bulgaria23.83
Poland22.25
France22.11
Spain21.56
Malta21.53
Ireland21.46
Italy20.01
Slovakia19.65
Belgium18.98
Croatia18.17
Luxembourg17.64
Iceland17.47
Portugal17.07
EU/EEA average16.94
Lithuania16.14
Norway14.01
Czechia13.93
Latvia13.44
Hungary13.34
Denmark13.32
Slovenia10.95
Estonia10.77
Finland10.49
Germany10.02
Austria8.79
Netherlands8.31

How has Irish antibiotic use changed over time?

Irish community use fell sharply during the pandemic, to a low of 16.30 in 2021. It then rose 31.6% in 2022, back to 21.46. The EU/EEA average rose 20.2% in the same year. Penicillins drove much of the Irish rebound, rising 43.7% from 2021 to 2022.

Over the longer run, the EU/EEA average fell 10.6% from 2013 to 2022, from 18.95 to 16.94. Ireland's figure rose 7.0%, from 20.05 to 21.46. Part of that rise is a jump in the "other antibacterials" group, from 0.03 in 2017 to 1.36 in 2018. The dataset does not say why. This suggests a change in what was counted, so we also checked the trend without that group: Ireland was then up 0.5% over the decade.

Our reading: Irish use has been broadly flat for ten years while the European average came down, so the gap widened.

Which antibiotics make up Ireland's total?

Ireland's community antibiotic use by group, 2022, doses per 1,000 inhabitants per day, with EU/EEA average in brackets (ECDC ESAC-Net via Airmid Éireann)
Antibiotic groupIreland (EU/EEA)
Penicillins (J01C)10.37 (7.48)
Tetracyclines (J01A)3.82 (1.69)
Macrolides and related (J01F)3.35 (3.09)
Other antibacterials (J01X)1.36 (1.10)
Cephalosporins and other beta-lactams (J01D)1.32 (1.92)
Sulfonamides and trimethoprim (J01E)0.85 (0.55)
Quinolones (J01M)0.39 (1.11)

Penicillins, the group that includes amoxicillin, made up 48.3% of Ireland's community use. Ireland ranked 4th of 28 for penicillins. It ranked 2nd of 28 for tetracyclines, at more than twice the EU/EEA average. Tetracycline use rose 29.1% from 2021 to 2022.

Ireland is low in two groups. It ranked 25th of 28 for quinolones, and its quinolone use fell 54.7% from 2013 to 2022. It ranked 17th of 27 for cephalosporins and other beta-lactams. Macrolide use fell 23.4% over the decade. ECDC's trend test shows quinolones and macrolides decreasing in Ireland.

What about antibiotic use in Irish hospitals?

In 2022 the hospital sector was 7.0% of Ireland's combined community and hospital use. Irish hospital use was 1.61 doses per 1,000 people per day, against an EU/EEA average of 1.58. Ireland ranked 12th of 26 countries.

Irish hospitals used 0.049 doses of carbapenems per 1,000 people per day, below the EU/EEA average of 0.054, ranking 17th of 26. ECDC's trend test shows a decrease for Ireland since 2013. "Reserve" antibiotics, a WHO category kept for the hardest infections, made up 3.4% of Irish hospital use, against an EU/EEA average of 5.2%. Ireland ranked 10th of 27.

Is the "Access" share available?

No. The EU aims for at least 65% of antibiotic use to come from the WHO "Access" group of first-choice drugs by 2030. ECDC's report for 2022 said only 10 countries met it that year. The Airmid tables have no Access share by country, so we cannot say where Ireland stands.

How to check these numbers

All figures come from the Airmid Éireann dataset ecdc_antimicrobial_consumption, available as a CSV file. It holds ECDC's downloadable tables D1 to D24 from the Annual Epidemiological Report for 2022. The file we used matched the SHA-256 fingerprint in the Airmid catalog.

  • Unit: defined daily doses (DDD) per 1,000 inhabitants per day. A DDD is a WHO standard adult dose.
  • Community use: sum of tables D1 to D7 (ATC J01A, J01C, J01D, J01E, J01F, J01M, J01X), 2013 to 2022. Three small groups are not in the tables, so the sum is slightly below ECDC's headline total: ECDC gives 17.0 for the EU/EEA in 2022, against our 16.94.
  • Hospital use: sum of D8 to D10 and D12 to D15. Carbapenems are table D11; Reserve share is D24.
  • Ranking: only countries reporting all seven groups. In 2022 that left out Cyprus, Sweden and the United Kingdom.
  • Average: the "EU/EEA" row, ECDC's population-weighted mean.

Countries' data sources and coverage differ. For example, ECDC notes that Finland's community figures include remote primary healthcare centres and nursing homes. Small gaps should be read with care. The analysis script is available on request. Dataset provided by ECDC based on data provided by public health authorities, scientific institutes or health care providers in the relevant reporting countries and/or by WHO. Airmid reshaped the tables; Priya Life Science summed groups and ranked countries. ECDC content is licensed under CC BY 4.0.

Frequently asked questions

Does Ireland use more antibiotics than the EU average?

Yes, outside hospitals. In 2024 Irish community use was 21.1 doses per 1,000 people per day against an EU/EEA average of 18.8. In hospitals, Ireland was close to the average in 2022, the latest year with hospital detail in Airmid.

Is 2022 the latest data?

No. ECDC's report for 2024 gives each country's total, which we quote at the top. The detailed tables by antibiotic group in Airmid Éireann run to 2022. We will update the breakdown when newer tables are added.

Why does high antibiotic use matter?

The more antibiotics are used, the more chances bacteria have to become resistant. These figures measure volume only, not whether each prescription was appropriate.

Should I stop taking an antibiotic I have been prescribed?

No. This article is not medical advice. Do not stop or change any treatment without talking to your doctor or pharmacist. More on the medicines in this class is on our antibiotics page.

Outlook

The EU aims to cut total antibiotic use by 20% by 2030 compared with 2019. In its report for 2024, ECDC put the EU/EEA total at 20.3 doses per 1,000 people per day, against a 2030 target of 15.9. In 2022, Irish community use was 2.2% above 2019. Our reading: Ireland would need a sustained fall, not just a return to pre-pandemic levels, to move towards that target. Priya Life Science will update this analysis when the newer ECDC tables are added to Airmid Éireann.

Sources

Cover image: "Antibiotic pills" by Maksym Kozlenko, via Wikimedia Commons, licensed CC BY-SA 4.0. Cropped and resized.

Reviewed for editorial accuracy by Sreepriya Prasannan, Founder & Editor MSc Digital Transformation of Life Sciences (Innopharma Education / Griffith College); MSc & BSc Botany
Our standards
Related from our data
Tetralysal 300 mg hard capsules — Tetracycline · Irish Medicines Database
Drugs in this article: current clinical trials
Most-trialled drugs in our registers
Browse all trial registers →

Get the Friday brief

One email every Friday: a 60-second summary, then only the topics you choose: industry news, approvals and market access, shortages, Irish trials, careers or data, all built from public registers.

Free. Unsubscribe from any email with one click. See our privacy policy.

About the Author
Sreepriya Prasannan

Sreepriya Prasannan

Writer at Priya Life Science · Pharmaceutical

Sreepriya Prasannan is the Founder and Editor of Priya Life Science, Ireland's independent pharma, biotech and MedTech platform. She holds an MSc in Digital Transformation (Life Science) from Griffith College Dublin, with a background in QA, GMP and production operations. Shortlisted for STEM Graduate of the Year at the Business Post Women in STEM Awards 2026 and a Top 14 finalist in the HSE Spark Ignite 2026 innovation programme, she writes on regulatory trends, GMP compliance and careers across the Irish and European life sciences.

Discussion
No comments yet. Be the first to share your thoughts!
Leave a Comment